Sionna Therapeutics (SION) Misses Q2 EPS by 14c

Sionna Therapeutics (NASDAQ: SION) reported Q2 EPS of ($0.66), $0.14 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Sionna Therapeutics (SION) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Fed’s Musalem says more rate hikes likely needed to curb inflation
• Black Hills Corp. (BKH) 3500 contracts of October 80 calls active, share price up 2.5%